Vericel Corp (VCEL)-Financial and Strategic SWOT Analysis Review

Vericel Corp (VCEL)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDME363FSA
  • |
  • Pages: 50
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Vericel Corp (VCEL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell therapy products in the US: Carticel, an autologous chondrocyte implant for the treatment of cartilage defects in the knee; and Epicel, a permanent skin replacement for the treatment of patients with deep-dermal. The company also develops MACI, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee; and ixmyelocel-T, a patient-specific multicellular therapy for the treating advanced heart failure. It has manufacturing facilities in Cambridge, Massachusetts; Ann Harbour, Michigan and Kastrup, Denmark. Vericel is headquartered in Cambridge, the US.

Vericel Corp Key Recent Developments

Apr 10,2017: Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs

Mar 10,2017: Vericel Reports Fourth-Quarter and Year-End 2016 Financial Results

Nov 07,2016: Vericel Reports Third-Quarter 2016 Financial Results

Sep 12,2016: Vericel Enters into Expanded $20 Million Credit Facility and Term Loan with Silicon Valley Bank and MidCap Financial Services

Aug 08,2016: Vericel Reports Second-Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Vericel Corp-Key Facts 6

Vericel Corp-Key Employees 7

Vericel Corp-Key Employee Biographies 8

Vericel Corp-Major Products and Services 10

Vericel Corp-Medical Equipment Pipeline Products Data 11

Vericel Corp Pipeline Products by Equipment Type 11

Vericel Corp Pipeline Products by Development Stage 12

Vericel Corp-History 14

Vericel Corp-Company Statement 16

Vericel Corp-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Section 2-Company Analysis 18

Vericel Corp-Business Description 18

Vericel Corp-Corporate Strategy 19

Vericel Corp-SWOT Analysis 20

SWOT Analysis-Overview 20

Vericel Corp-Strengths 20

Vericel Corp-Weaknesses 21

Vericel Corp-Opportunities 22

Vericel Corp-Threats 23

Vericel Corp-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Vericel Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 31

Vericel Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017 32

Vericel Corp, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Apr 10, 2017: Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs 34

Mar 10, 2017: Vericel Reports Fourth-Quarter and Year-End 2016 Financial Results 35

Nov 07, 2016: Vericel Reports Third-Quarter 2016 Financial Results 37

Sep 12, 2016: Vericel Enters into Expanded $20 Million Credit Facility and Term Loan with Silicon Valley Bank and MidCap Financial Services 39

Aug 08, 2016: Vericel Reports Second-Quarter 2016 Financial Results 40

May 10, 2016: Vericel Reports First-Quarter 2016 Financial Results 42

Mar 14, 2016: Vericel Reports Fourth-Quarter and Year-End 2015 Financial Results 43

Mar 07, 2016: Vericel Announces FDA Acceptance for Filing of BLA for MACI for the Treatment of Symptomatic Cartilage Defects in the Knee 45

Section 6-Appendix 46

Methodology 46

Ratio Definitions 46

About GlobalData 50

Contact Us 50

Disclaimer 50

List of Figures

Vericel Corp Pipeline Products by Equipment Type 11

Vericel Corp Pipeline Products by Development Stage 12

Vericel Corp, Performance Chart (2012-2016) 28

Vericel Corp, Ratio Charts 30

Vericel Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 31

Vericel Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 32

List of Tables

Vericel Corp, Key Facts 6

Vericel Corp, Key Employees 7

Vericel Corp, Key Employee Biographies 8

Vericel Corp, Major Products and Services 10

Vericel Corp Pipeline Products by Equipment Type 11

Vericel Corp Number of Pipeline Products by Development Stage 12

Vericel Corp Pipeline Products Summary by Development Stage 13

Vericel Corp, History 14

Vericel Corp, Subsidiaries 17

Vericel Corp, Key Competitors 24

Vericel Corp, Ratios based on current share price 25

Vericel Corp, Annual Ratios 26

Vericel Corp, Annual Ratios (Cont...1) 27

Vericel Corp, Interim Ratios 29

Vericel Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 31

Vericel Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017 32

Vericel Corp, Recent Deals Summary 33

Currency Codes 46

Capital Market Ratios 46

Equity Ratios 47

Profitability Ratios 47

Cost Ratios 48

Liquidity Ratios 48

Leverage Ratios 49

Efficiency Ratios 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Vericel Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8071
Site License
USD 250 INR 16143
Corporate User License
USD 375 INR 24214

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com